Immune Reconstitution in HIV Disease (IREHIV)

PHASE2CompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
HIV Infection
Interventions
DRUG

vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate)

Dose of interventions: 5,000 IU of vitamin D (cholecalciferol tablets) once daily and 500 mg PBA (sodium phenylbutyrate tablets) twice daily for 16 weeks.

DRUG

Placebo tablets

Placebo tablets for vitamin D once daily and placebo tablets for PBA (phenylbutyrate) twice daily for 16 weeks.

Trial Locations (1)

Unknown

Black Lion Hospital (BLH), Addis Ababa University, Faculty of Medicine, Addis Ababa

All Listed Sponsors
collaborator

Addis Ababa University

OTHER

collaborator

Armauer Hansen Research Institute, Ethiopia

OTHER

lead

Karolinska Institutet

OTHER

NCT01702974 - Immune Reconstitution in HIV Disease (IREHIV) | Biotech Hunter | Biotech Hunter